文献速递慢性肾脏病肾血管病与高血压

收缩压与CKD G3-G5发病风险的关联:韩国成年人队列研究

Associations of Systolic Blood Pressure With Incident CKD G3-G5: A Cohort Study of South Korean Adults.
PubMed 文献 · Am J Kidney Dis · 2020-04-15

中位随访49,169,311人年期间,172,423人(1.64%)发生CKD G3-G5,粗发病率为3.51/1000人年。与基线SBP 120-129 mmHg相比,SBP≥140 mmHg者风险增高(HR 1.30),时间更新分析中风险更高(HR 2.49),每升高10 mmHg风险增加35%。

要点

  • 基线收缩压≥130 mmHg与CKD G3-G5风险增加相关,呈剂量依赖性。
  • 时间更新收缩压分析显示更高收缩压与更高CKD风险 strongly 关联。
  • 研究支持评估降压策略以降低CKD发生风险。

核心结论

  • 在韩国大规模队列中,较高的收缩压与CKD G3-G5发病风险增高相关,支持评估降压策略以降低CKD发生。

主要发现

  • 随访49,169,311人年期间,172,423人(1.64%)发生CKD G3-G5,粗事件率为3.51(95%CI 3.49-3.52)/1000人年。
  • 与基线SBP 120-129 mmHg相比,<110、110-119、130-139、≥140 mmHg的HR分别为0.84(95%CI 0.82-0.85)、0.92(95%CI 0.91-0.94)、1.11(95%CI 1.09-1.12)、1.30(95%CI 1.28-1.31)。
  • 时间更新SBP相应HR分别为0.57(95%CI 0.56-0.59)、0.79(95%CI 0.78-0.80)、1.58(95%CI 1.55-1.60)、2.49(95%CI 2.45-2.53)。
  • SBP每升高10 mmHg,CKD G3-G5风险增加35%(95%CI 1.35-1.36)。

临床怎么用

  • 对于eGFR≥60的成年人,收缩压≥130 mmHg时应关注CKD风险,考虑个体化血压管理。

局限性

  • 使用ICD代码评估合并症负担;不能排除残余混杂和潜在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Clinical practice guidelines recommend a target blood pressure (BP)<130/80 mm Hg to reduce cardiovascular risk. However, the optimal BP to prevent chronic kidney disease (CKD) is unknown. STUDY DESIGN: Population-based retrospective cohort study. SETTING & PARTICIPANTS: 10.5 million adults who participated in the National Health Insurance Service National Health Checkup Program in South Korea between 2009 and 2015 and had an estimated glomerular filtration rate (GFR) ≥ 60 mL/min/1.73 m2 at the beginning of follow-up. PREDICTORS: Baseline and time-updated systolic BP (SBP) as a continuous variable and categorized as<110, 110 to 119, 120 to 129, 130 to 139, or≥140 mm Hg. OUTCOME: Incident CKD GFR categories 3 to 5 (CKD G3-G5), defined as de novo development of estimated GFR<60 mL/min/1.73 m2 for at least 2 consecutive assessments confirmed at least 90 days apart. ANALYTICAL APPROACH: Cox proportional hazards regression for baseline BP and marginal structural analysis for time-updated BP. RESULTS: During 49,169,311 person-years of follow-up, incident CKD G3-G5 developed in 172,423 (1.64%) individuals with a crude event rate of 3.51 (95% CI, 3.49-3.52) per 1,000 person-years. Compared to a baseline SBP of 120 to 129 mm Hg, HRs for incident CKD G3-G5 for the<110, 110 to 119, 130 to 139, and≥140 mm Hg categories were 0.84 (95% CI, 0.82-0.85), 0.92 (95% CI, 0.91-0.94), 1.11 (95% CI, 1.09-1.12), and 1.30 (95% CI, 1.28-1.31), respectively. For time-updated SBPs, corresponding HRs were 0.57 (95% CI, 0.56-0.59), 0.79 (95% CI, 0.78-0.80), 1.58 (95% CI, 1.55-1.60), and 2.49 (95% CI, 2.45-2.53), respectively. Treated as a continuous exposure, each 10-mm Hg higher SBP was associated with 35% higher risk for incident CKD G3-G5 (95% CI, 1.35-1.36). LIMITATIONS: Use of International Classification of Diseases codes to assess comorbid condition burden; residual confounding, and potential selection bias cannot be excluded. CONCLUSIONS: In this large national cohort study, higher SBPs were associated with higher risk for incident CKD G3-G5. These findings support evaluation of SBP-lowering strategies to reduce the development of CKD.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Chang TI, Lim H, Park CH, et al. Associations of Systolic Blood Pressure With Incident CKD G3-G5: A Cohort Study of South Korean Adults. Am J Kidney Dis. 2020. PMID: 32305207. doi:10.1053/j.ajkd.2020.01.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。